Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04403022 · ClinicalTrials.gov registry record · NA
da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures
A NA study of Colorectal Cancer and Benign or Malignant Rectal or Colon Tumors, sponsored by Intuitive Surgical.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 9
- Study locations
NCT04403022: Active NA study of Colorectal Cancer and Benign or Malignant Rectal or Colon Tumors, sponsored by Intuitive Surgical.
NCT04403022 is a NA study of Colorectal Cancer and Benign or Malignant Rectal or Colon Tumors that is active but no longer recruiting, run by Intuitive Surgical. The registered enrollment target is 60 participants, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (96% lower). The trial reports 9 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04403022, a NA study of Colorectal Cancer and Benign or Malignant Rectal or Colon Tumors, is active but no longer recruiting, sponsored by Intuitive Surgical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 9
- Study locations
Study Summary
To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in a complex colorectal procedure such as low anterior resections or right colectomy.
Conditions Studied
Interventions
- DEVICE Robotic Assisted Surgery
Study Locations (9)
Florida
- Adventist Health System/Sunbelt - Orlando
Michigan
- Henry Ford - Detroit
Minnesota
- Mayo Clinic - Rochester
Nevada
- MountianView Hospital - Las Vegas
Pennsylvania
- Allegheny General Hospital - Pittsburgh
Texas
- Houston Methodist Research Institute - Houston
Washington
- MultiCare - Tacoma - Tacoma
Dong-gu
- Ulsan University Hospital - Ulsan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-06-03 |
| Est. Completion | 2028-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04403022
The ClinicalTrials.gov registry entry for NCT04403022 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Intuitive Surgical, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Robotic Assisted Surgery is the first listed.
NCT04403022 reports 9 study locations spanning 9 distinct geographic areas - top geographies include Florida, Michigan, Minnesota.
Frequently Asked Questions
What is clinical trial NCT04403022 about?
NCT04403022 is a clinical study titled "da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures". To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in a complex colorectal procedure such as low anterior resections or right colectomy.
What is the current status of trial NCT04403022?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-06-03. Estimated completion is 2028-11-30.
What conditions does trial NCT04403022 study?
This clinical trial studies the following conditions: Colorectal Cancer, Benign or Malignant Rectal or Colon Tumors.
What interventions are being tested in trial NCT04403022?
The interventions under investigation include: Robotic Assisted Surgery (DEVICE).
Who is sponsoring clinical trial NCT04403022?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04403022 being conducted?
This trial has 9 study locations across Florida, Michigan, Minnesota, Nevada, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.